Analyst Ratings For Apollo Endosurgery (NASDAQ:APEN)
Today, Northland Securities reiterated its Buy rating on Apollo Endosurgery (NASDAQ:APEN) with a price target of $12.00.
Some recent analyst ratings include
- 2/8/2018-Northland Securities Reiterated Rating of Buy.
- 7/24/2017-Craig Hallum initiated coverage with a Buy rating.
Recent Insider Trading Activity For Apollo Endosurgery (NASDAQ:APEN)
Apollo Endosurgery (NASDAQ:APEN) has insider ownership of 74.20% and institutional ownership of 23.67%.
- On 12/29/2018 Stonepine Capital, L.P., Major Shareholder, bought 5,163 with an average share price of $5.56 per share and the total transaction amounting to $28,706.28.
- On 1/3/2018 Stonepine Capital, L.P., Major Shareholder, bought 22,845 with an average share price of $5.71 per share and the total transaction amounting to $130,444.95.
- On 12/26/2017 Stonepine Capital, L.P., Major Shareholder, bought 5,287 with an average share price of $5.00 per share and the total transaction amounting to $26,435.00.
- On 12/22/2017 Stonepine Capital, L.P., Major Shareholder, bought 185,157 with an average share price of $4.85 per share and the total transaction amounting to $898,011.45.
- On 12/20/2017 Stonepine Capital, L.P., Major Shareholder, bought 45,434 with an average share price of $4.50 per share and the total transaction amounting to $204,453.00.
- On 11/7/2017 Bret Schwartzhoff, VP, bought 9,500 with an average share price of $4.24 per share and the total transaction amounting to $40,280.00.
- On 7/26/2017 Holdings A/S Novo, Major Shareholder, sold 50,130 with an average share price of $6.90 per share and the total transaction amounting to $345,897.00.
Recent Trading Activity for Apollo Endosurgery (NASDAQ:APEN)
Shares of Apollo Endosurgery closed the previous trading session at 6.19 up +0.13 2.15% with 6.230000019073486 shares trading hands.
